Compass Therapeutics (CMPX) Change in Account Payables (2019 - 2026)
Compass Therapeutics (CMPX) reported Change in Account Payables of -$679000.0 for Q1 2026, down 1.04% on a YoY basis from -$686147.4 in Q1 2025, and up 55.03% sequentially from -$1.5 million in Q4 2025.
Compass Therapeutics (CMPX) Change in Account Payables (2019 - 2026) Analysis & Trends
Compass Therapeutics (CMPX) has 8 years of Change in Account Payables data on file, last reported at -$679000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables fell 1.04% year-over-year to -$679000.0; the trailing twelve-month figure through Mar 2026 stood at -$671000.0 (down 192.81% YoY), and the FY2025 full-year result was -$664000.0, up 63.93% from the prior year.
- Change in Account Payables improved to -$679000.0 in Q1 2026, from -$1.5 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $6.2 million in Q2 2022 to a low of -$3.7 million in Q3 2022.
- A 5-year average of $2294.1 and a median of -$232000.0 in 2024 frame the typical range for Change in Account Payables.
- Peak annual rise in Change in Account Payables reached 62200.0% in 2022, while the deepest fall reached 1295.47% in 2022.
- Tracing CMPX's Change in Account Payables over 5 years: stood at $621000.0 in 2022, then soared by 187.28% to $1.8 million in 2023, then decreased by 27.75% to $1.3 million in 2024, then sank by 217.15% to -$1.5 million in 2025, then jumped by 55.03% to -$679000.0 in 2026.
- Business Quant data shows CMPX's Change in Account Payables at -$679000.0 in Q1 2026, -$1.5 million in Q4 2025, and $500000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Compass Therapeutics | 395.17 Mn | 200.48 Mn | - | -679,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -679,000.00 |
| Mar 31, 2026 | -679,000.00 |
| Dec 31, 2025 | -1.51 Mn |
| Dec 31, 2025 | -1.51 Mn |
| Sep 30, 2025 | 500,000.00 |
| Sep 30, 2025 | 500,000.00 |
| Jun 30, 2025 | 1.02 Mn |
| Jun 30, 2025 | 1.02 Mn |
| Mar 31, 2025 | -672,000.00 |
| Mar 31, 2025 | -672,000.00 |
| Dec 31, 2024 | 1.29 Mn |
| Dec 31, 2024 | 1.29 Mn |
| Sep 30, 2024 | -232,000.00 |
| Sep 30, 2024 | -232,000.00 |
| Jun 30, 2024 | 338,000.00 |
| Jun 30, 2024 | 338,000.00 |
| Mar 31, 2024 | -3.24 Mn |
| Mar 31, 2024 | -3.24 Mn |
| Dec 31, 2023 | 1.78 Mn |
| Dec 31, 2023 | 1.78 Mn |